Unibest 优贝德
← Back to patent-cliff list

马昔腾坦

Tier B — Position early

Macitentan

Actelion Pharmaceuticals Ltd
Originator
2013
First approval
-
Expiry (public)
$2.18B ▲
Peak sales
化学药
Type

TargetsETAR、ETBR

BrandOpsumit、傲朴舒、Zependo

Indications (approved)肺动脉高压

Regional status

US
批准上市
2013-10-18
EU
批准上市
2013-12-20
China
批准上市
2017-09-29
Japan
批准上市
2015-03-26

Synthetic routes & intermediates2 routes

Originator routes × 1Optimised (non-patent) × 1Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OriginatorRoute 1Steps 11 · Total yield 11.99 g
Synthetic routes & intermediates Route 1
CodeCAS No.Intermediate
MACI-0011878-68-82-(4-bromophenyl)acetic acid
MACI-00241841-16-1methyl 2-(4-bromophenyl)acetate
MACI-003616-38-6dimethyl carbonate
MACI-004149506-35-4dimethyl 2-(4-bromophenyl)malonate
MACI-0056313-33-3formimidamide hydrochloride
MACI-006706811-25-85-(4-bromophenyl)pyrimidine-4,6-diol
MACI-007146533-41-75-(4-bromophenyl)-4,6-dichloropyrimidine
MACI-008-potassium (N-propylsulfamoyl)amide
MACI-0091393813-42-7-
MACI-010107-21-1Availableethane-1,2-diol
MACI-0111393813-43-8-
MACI-01232779-36-55-bromo-2-chloropyrimidine
MACI-0131189-71-5sulfurisocyanatidic chloride
MACI-01475-65-02-methylpropan-2-ol
MACI-015-tert-butyl chlorosulfonylcarbamate
MACI-016107-10-8propan-1-amine
MACI-0171393813-40-5tert-butyl N-propylsulfamoylcarbamate
MACI-018147962-41-2 (free)-
OptimisedRoute 2Steps 4 · Total yield 225 g
Synthetic routes & intermediates Route 2
CodeCAS No.Intermediate
MACI-007146533-41-75-(4-bromophenyl)-4,6-dichloropyrimidine
MACI-0091393813-42-7-
MACI-0111393813-43-8-
MACI-01232779-36-55-bromo-2-chloropyrimidine
MACI-0131189-71-5sulfurisocyanatidic chloride
MACI-016107-10-8propan-1-amine
MACI-019147962-41-2-
MACI-0207580-85-02-(tert-butoxy)ethanol

Frequently asked questions

What are the approved indications of Macitentan?

Approved indications include: 肺动脉高压.

When does the Macitentan patent expire?

No public expiry year is available for Macitentan yet; this page updates once verified.

How many synthesis routes are recorded for Macitentan?

2 synthesis routes are recorded; the shortest is 4 steps with 225 g total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Macitentan intermediates?

1 intermediate CAS of Macitentan are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.

How do I get a quote for Macitentan intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-09-24